Evropska unija - slovenščina - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin - diabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 in 5. 1 za razpoložljive podatke o različnih kombinacijah).

Evropska unija - slovenščina - EMA (European Medicines Agency)

eli lilly nederland b.v. - dulaglutid - diabetes mellitus, tip 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. za študijski rezultati glede na kombinacije, vplivi na glycaemic nadzor in srčno-žilne dogodke, in populacije, ki je študiral glej poglavji 4. 4, 4. 5 in 5.

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharma a/s - alogliptin benzoata, metformin hidroklorid - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - vipdomet is indicated in the treatment of adult patients aged 18 years and older with type-2 diabetes mellitus:as an adjunct to diet and exercise to improve glycaemic control in adult patients, inadequately controlled on their maximal tolerated dose of metformin alone, or those already being treated with the combination of alogliptin and metformin;in combination with pioglitazone (i. triple combination therapy) as an adjunct to diet and exercise in adult patients inadequately controlled on their maximal tolerated dose of metformin and pioglitazone;in combination with insulin (i. trojna kombinacija terapija), kot dodatek k prehrani in vadbi za izboljšanje glycaemic nadzor pri bolnikih, pri insulina na stabilen odmerek in metforminom sam ne zagotavljajo ustrezne glycaemic nadzor.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - metformin hidroklorid, dapagliflozin propanediol monohidrat - diabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - xigduo je navedeno pri odraslih za zdravljenje diabetesa tipa 2 bolezni, kot dodatek k prehrani in izvajanje:• pri bolnikih, premalo nadzorovana na njihovo maksimalno dopustne odmerek metforminom sam • v kombinaciji z drugimi zdravili za zdravljenje sladkorne bolezni pri bolnikih zadostno nadzorovana z metforminom in teh zdravil• pri bolnikih, ki se že zdravijo z kombinacijo dapagliflozin in metforminom kot ločene tablete. za študijski rezultati glede kombinacija terapij, vplivi na glycaemic nadzor in srčno-žilne dogodke, in populacije, ki je študiral glej poglavji 4. 4, 4. 5 in 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - sumatriptan - obložena tableta - sumatriptan 50 mg / 1 tableta - sumatriptan

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - sumatriptan - obložena tableta - sumatriptan 100 mg / 1 tableta - sumatriptan

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - sumatriptan - obložena tableta - sumatriptan 50 mg / 1 tableta - sumatriptan

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

actavis group ptc ehf. - sumatriptan - obložena tableta - sumatriptan 100 mg / 1 tableta - sumatriptan

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - oksikodon - tableta s podaljšanim sproščanjem - oksikodon 17,9 mg / 1 tableta - oksikodon

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - oksikodon - tableta s podaljšanim sproščanjem - oksikodon 35,9 mg / 1 tableta - oksikodon